Cue Biopharma Cash Flow Statement (2017-2025)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	-18.83M	-10.30M	-14.30M	-7.89M	-14.33M	-13.30M	-11.15M	-15.08M	-13.71M	-13.66M	-12.13M	-13.16M	-18.81M	-15.67M	-9.63M	-9.19M	-16.21M	-14.56M	-8.18M	1.96M
Depreciation and Depletion (Quarter)	0.22M	0.23M	0.23M	0.23M	0.22M	0.21M	0.20M	0.20M	0.17M	0.10M	0.10M	0.14M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.08M	0.07M
Share-based Compensation (Quarter)	23.05M	21.20M	18.12M		18.53M	2.31M	13.86M	0.44M	2.00M	11.00M	2.07M	2.07M	1.95M	9.20M	7.20M	1.56M	1.34M	1.26M	1.53M	0.61M
Asset Writedowns and Impairment (Quarter)
Cash from Operations (Quarter)	-11.79M	-9.77M	-6.63M	-10.65M	-11.57M	-12.85M	-6.87M	-10.51M	-10.83M	-10.37M	-7.80M	-10.96M	-9.78M	-9.99M	-7.53M	-9.03M	-8.17M	-3.42M	-9.02M	-1.08M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	-0.01M			419.00			-0.10M	-0.22M	-0.15M	-0.07M	-0.01M									-0.03M
Amortization of Deferred Charges (Quarter)					0.00M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M
Depreciation & Amortization (CF) (Quarter)	0.32M	0.31M	0.32M	0.31M	0.30M	0.21M	0.20M	0.20M	0.18M	0.14M	0.13M	0.11M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.08M	0.68M
Change in Working Capital
Change in Receivables (Quarter)	-0.00M	0.49M	-1.13M	2.37M	-2.22M	-0.19M	0.06M	-0.74M	0.14M	0.94M	0.53M	0.04M	-0.30M	0.45M	1.30M	-2.21M	-0.94M	0.53M	-0.14M	5.16M
Change in Account Payables (Quarter)	0.20M	0.72M	-0.52M	0.12M	0.03M	-1.05M	0.48M	0.63M	-0.58M	0.20M	0.12M	1.02M	0.42M	-0.01M	2.57M	-3.65M	0.96M	-0.16M	-1.28M	1.60M
Change in Accured Expenses (Quarter)	-0.81M	0.03M	1.99M	0.63M	-1.22M	0.15M	0.32M	-0.33M	-0.71M	1.23M	1.05M	-0.98M	1.07M	-0.65M	-1.36M	-0.29M	1.32M	-2.71M	0.35M	-0.26M
Other Working Capital Changes (Quarter)	1.59M	1.20M	-1.92M	-0.82M	0.10M	1.17M	-0.42M	-1.58M	1.52M	-0.45M	-0.75M	-3.11M	-0.74M	0.74M	-2.31M	0.32M	1.08M	0.47M	-3.60M	-0.52M
Investing Activities
Capital Expenditures (Quarter)	0.65M	0.25M	0.01M	39.00	0.03M	0.07M	0.08M	0.00M					0.06M	0.01M	-0.00M	0.00M	0.15M	0.03M
Sales of Property, Plant and Equipment (Quarter)			0.00M	550.00		0.00M	0.00M		0.00M						0.10M	0.00M				0.02M
Cash from Investing Activities (Quarter)	9.35M	-0.23M	-0.01M	511.00	-0.03M	-0.06M	-29.52M	5.00M	15.00M	5.00M	5.00M		-0.06M	-0.01M	0.10M	-0.00M	-0.15M	-0.03M	-6.77M	7.02M
Financing Activities
Other financing activities (Quarter)	0.92M	9.44M	-8.30M	15.32M			16.60M		0.39M	0.09M	7.13M	5.78M	3.35M			0.06M		0.75M	1.00M	0.75M
Cash from Financing Activities (Quarter)	0.83M	10.67M	0.35M	7.38M	15.16M	11.11M	-0.01M	27.40M	0.39M	2.10M	4.59M	4.78M	2.35M	-1.00M	9.82M	-0.93M	-1.00M	17.80M	0.00M	9.49M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)															10.82M	-0.01M				10.24M
Additional items
Change in Cash (Quarter)	-1.61M	0.66M	-6.29M	-3.26M	3.56M	-1.80M	-36.40M	21.89M	4.56M	-3.27M	1.79M	-6.18M	-7.49M	-11.00M	2.39M	-9.96M	-9.32M	14.36M	-15.79M	15.44M
Free Cash Flow (Quarter)	-12.44M	-10.02M	-6.64M	-10.65M	-11.60M	-12.91M	-6.95M	-10.52M	-10.83M	-10.37M	-7.80M	-10.96M	-9.84M	-10.00M	-7.53M	-9.03M	-8.32M	-3.44M	-9.02M	-1.08M
Net Cash Flow (Quarter)	-1.61M	0.66M	-6.29M	-3.26M	3.56M	-1.80M	-36.40M	21.89M	4.56M	-3.27M	1.79M	-6.18M	-7.49M	-11.00M	2.39M	-9.96M	-9.32M	14.36M	-15.79M	15.44M

Research Tools

Datasets

Plans

Developers

Cue Biopharma CUE Cash Flow Statement (2017-2025)

Research Tools

Datasets

Plans

Developers

Cue Biopharma CUE Cash Flow Statement (2017-2025)

Create an account

Sign In

Reset Password